These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 19900151

  • 1. Association of the PPARGC1A gene polymorphism with diabetic nephropathy in an Asian Indian population (CURES-41).
    Gayathri SB, Radha V, Vimaleswaran KS, Mohan V.
    Metab Syndr Relat Disord; 2010 Apr; 8(2):119-26. PubMed ID: 19900151
    [Abstract] [Full Text] [Related]

  • 2. Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians.
    Vimaleswaran KS, Radha V, Anjana M, Deepa R, Ghosh S, Majumder PP, Rao MR, Mohan V.
    Int J Obes (Lond); 2006 Jun; 30(6):884-91. PubMed ID: 16446747
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A, Medica I, Salobir B, Tercelj-Zorman M, Sabovic M, Petrovic D, Peterlin B.
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [Abstract] [Full Text] [Related]

  • 5. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM, Weisnagel SJ, Vohl MC, Rankinen T, Bouchard C, Pérusse L.
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [Abstract] [Full Text] [Related]

  • 6. Association between PPARGC1A gene polymorphisms and coronary artery disease in a Chinese population.
    Zhang Y, Xu W, Li X, Tang Y, Xie P, Ji Y, Fan L, Chen Q.
    Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1172-7. PubMed ID: 18565194
    [Abstract] [Full Text] [Related]

  • 7. [Association study between PPARGC1A Thr394Thr/ Gly482Ser polymorphisms and type 2 diabetes].
    Su Y, Peng SB, Li ZQ, Huang QY.
    Yi Chuan; 2008 Mar; 30(3):304-8. PubMed ID: 18331997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of the peroxisome proliferator activated receptor-γ coactivator-1α (PGC-1α) Thr394Thr and Gly482Ser polymorphisms on rosiglitazone response in Chinese patients with type 2 diabetes mellitus.
    Zhang KH, Huang Q, Dai XP, Yin JY, Zhang W, Zhou G, Zhou HH, Liu ZQ.
    J Clin Pharmacol; 2010 Sep; 50(9):1022-30. PubMed ID: 20498286
    [Abstract] [Full Text] [Related]

  • 10. [PPARGC1A gene Thr394Thr G/A polymorphism and its association with type 2 diabetes mellitus and insulin resistance in a Chinese population].
    Song J, Liu YY, Long Y, Tian HM, Liu R, Li XJ, Chen T, Zhang XX, Yu HL, Ren Y.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Oct; 27(5):550-3. PubMed ID: 20931535
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PPARGC1A) gene polymorphisms and type 2 diabetes mellitus: a meta-analysis.
    Yang Y, Mo X, Chen S, Lu X, Gu D.
    Diabetes Metab Res Rev; 2011 Feb; 27(2):177-84. PubMed ID: 21294239
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of Association of Metabolic Syndrome with PPARGC1A, PPARG and UCP1 Gene Polymorphisms in Asian Indians.
    Vimaleswaran KS, Radha V, Deepa R, Mohan V.
    Metab Syndr Relat Disord; 2007 Jun; 5(2):153-62. PubMed ID: 18370824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
    Hui Y, Yu-Yuan L, Yu-Qiang N, Wei-Hong S, Yan-Lei D, Xiao-Bo L, Yong-Jian Z.
    Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.